Immunogenicity and reactogenicity of heterologous ChAdOx1 nCoV-19/mRNA vaccination | Nature Medicine
Heterologous versus homologous COVID-19 booster vaccination in previous recipients of two doses of CoronaVac COVID-19 vaccine in Brazil (RHH-001): a phase 4, non-inferiority, single blind, randomised study - The Lancet
Homologous and Heterologous Covid-19 Booster Vaccinations | NEJM
SII seeks inclusion of Covid jab Covovax in CoWIN portal as heterologous booster dose for adults, ET HealthWorld
What is a heterologous booster COVID vaccine, and why should you take this jab?, ET HealthWorld
Heterologous mRNA vaccine booster increases neutralization of SARS-CoV-2 Omicron BA.2 variant | Signal Transduction and Targeted Therapy
Effectiveness of homologous and heterologous booster doses for an inactivated SARS-CoV-2 vaccine: a large-scale prospective cohort study - The Lancet Global Health
A 'mix and match' approach to SARS-CoV-2 vaccination | Nature Medicine
Vaccines | Free Full-Text | Heterologous Booster Dose with CORBEVAX following Primary Vaccination with COVISHIELD Enhances Protection against SARS-CoV-2
SII seeks inclusion of Covid jab Covovax in CoWIN portal as heterologous booster dose for adults
Study finds heterologous vaccine booster evokes robust immunity to SARS-CoV-2 Omicron variant
Safety of heterologous primary and booster schedules with ChAdOx1-S and BNT162b2 or mRNA-1273 vaccines: nationwide cohort study | The BMJ
Comparing the SARS-CoV-2-specific antibody response in human milk after homologous and heterologous booster vaccinations | Communications Biology
Vaccines | Free Full-Text | Heterologous Booster Dose with CORBEVAX following Primary Vaccination with COVISHIELD Enhances Protection against SARS-CoV-2
Frontiers | The acceptance to heterologous booster vaccination of COVID-19 vaccine among HCWs and targeted population: A cross-sectional study in central China
Full article: Pivoting to protein: the immunogenicity and safety of protein-based NVX-CoV2373 as a heterologous booster for inactivated and viral vector COVID-19 vaccines
DCGI approves Biological E's COVID-19 vaccine Corbevax as heterologous booster dose | Zee Business
What is a heterologous booster vaccine? | The Hindu - YouTube
What is a COVID-19 Heterologous Booster? | What is a #COVID19 Heterologous Booster? Also called a “mix and match” #booster dose, the CDC is allowing eligible individuals to choose which COVID-19...
Comparative effectiveness of heterologous third dose vaccine schedules against severe covid-19 during omicron predominance in Nordic countries: population based cohort analyses | The BMJ
Safety, immunogenicity, and efficacy of the mRNA vaccine CS-2034 as a heterologous booster versus homologous booster with BBIBP-CorV in adults aged ≥18 years: a randomised, double-blind, phase 2b trial - The Lancet
Valneva Reports Further Positive Phase 3 Immunogenicity and the First Heterologous Booster Results for its Inactivated, Adjuvanted COVID-19 Vaccine VLA2001 - Valneva
Effectiveness of Homologous or Heterologous Covid-19 Boosters in Veterans | NEJM
CORBEVAX gets EUA from Health Ministry as heterologous COVID-19 booster shot for 18 years and above - Express Pharma
